Purple Biotech Appoints Senior Business Development Executive Fabien Sebille as Chief Business Officer

NEXT STORY
Outlook on the Point of Care Diagnostics Global Market to 2028 – Featuring Danaher, Bio-Rad Laboratories and Abbott Among Others
PREV STORY
Bispecific Antibodies Cancer Immunotherapy Clinical Trials Insight 2028
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

atai Life Sciences Increases Loan in Principal by US$6m to Support IntelGenx’s Graduation to Toronto Stock Exchange After Positive Early Feasibility Study Data

author_avatar
NASDAQ Market News

Press release: Terveystalo renews its management structure – decision making and service development closer to the customer

The business environment in health care is experiencing great change. In order to ensure ...

author_avatar
NASDAQ Market News

FDA approves Roche’s OCREVUS® (ocrelizumab) shorter 2-hour infusion for relapsing and primary progressive multiple sclerosis

author_avatar
NASDAQ Market News